Granite Investment Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-13,329
Closed -$1.54M 297
2020
Q4
$1.54M Sell
13,329
-1,208
-8% -$135K 0.05% 208
2020
Q3
$1.42M Buy
14,537
+187
+1% +$21.5K 0.06% 208
2020
Q2
$1.76M Buy
14,350
+409
+3% +$46.4K 0.08% 191
2020
Q1
$1.22M Buy
+13,941
New +$1.48M 0.08% 199

Other funds holding GWPH

Granite Investment Partners's GWPH Position: Q1 2021 in Review

Granite Investment Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 13,329 shares — an estimated $1.54M sold.

Granite Investment Partners first reported a position in GWPH in Q1 2020 and held it in 4 quarters. The position peaked at $1.76M in Q2 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Granite Investment Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Granite Investment Partners sold 13,329 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $1.54M.
  • Granite Investment Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2020 and held it in 4 quarters.
  • Granite Investment Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.76M in Q2 2020.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Granite Investment Partners's 13F filing for Q1 2021, filed 13 May 2021.